Evaluation of the safety of transgenic rice containing peptides from Japanese cedar pollen allergens
- Conditions
- Healthy Individual
- Registration Number
- JPRN-UMIN000010212
- Lead Sponsor
- Department of Molecular Immunology, Institute of DNA Medicine, The Jikei University, School of Medicine.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 18
Not provided
1) A person with a BMI values under 17, or over 28. 2) A person who has hay fever and/or medical history of other allergic disorder. 3) Preliminarily examined positive at more than one of followings; Rhinoscopic examination, Nasal mucosa test, Nasal discharged eosinophil, Intradermal reaction and cedar-pollen specific IgE antibody. 4) A person with a medical history of rice allergy. 5) A person who has a disease which is undergoing treatment 6) A person with serious conditions such as diabetes, hepatic disease, and cardiac disease. 7) A person preliminarily ruled unfit to become a clinical study patient. 8) A person already in another clinical test when this clinical test begins. 9) A person who's presently breastfeeding, in pregnancy, or planning/wishing to be a pregnant during a period of clinical test. 10) A person whom trial investigator has assessed as mismatched participant.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method